T cell receptor restriction of diabetogenic autoimmune NOD T cells

被引:82
作者
Simone, E [1 ]
Daniel, D [1 ]
Schloot, N [1 ]
Gottlieb, P [1 ]
Babu, S [1 ]
Kawasaki, E [1 ]
Wegmann, D [1 ]
Eisenbarth, GS [1 ]
机构
[1] UNIV COLORADO,HLTH SCI CTR,BARBARA DAVIS CTR CHILDHOOD DIABET,DENVER,CO 80262
关键词
insulin; alpha chain; autoimmunity; type I diabetes;
D O I
10.1073/pnas.94.6.2518
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Restricted use of T cell receptor (TCR) gene segments is characteristic of several induced autoimmune disease models, TCR sequences have previously been unavailable for pathogenic T cells which react with a defined autoantigen in a spontaneous autoimmune disease, The majority of T cell clones, derived from islets of NOD mice which spontaneously develop type I diabetes, react with insulin peptide B-(9-23). We have sequenced the alpha and beta chains of TCRs from these B-(9-23)-reactive T cell clones. No TCR beta chain restriction was found. In contrast, the clones (10 of 13) used V alpha 13 coupled with one of two homologous J alpha segments (J alpha 45 or J alpha 34 in 8 of 13 clones). Furthermore, 9 of 10 of the V alpha 13 segments are a novel NOD sequence that we have tentatively termed V alpha 13.3. This dramatic alpha chain restriction, similar to the beta chain restriction of other autoimmune models, provides a target for diagnostics and immunomodulatory therapy.
引用
收藏
页码:2518 / 2521
页数:4
相关论文
共 25 条
[1]   LIMITED HETEROGENEITY OF T-CELL RECEPTORS FROM LYMPHOCYTES MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS ALLOWS SPECIFIC IMMUNE INTERVENTION [J].
ACHAORBEA, H ;
MITCHELL, DJ ;
TIMMERMANN, L ;
WRAITH, DC ;
TAUSCH, GS ;
WALDOR, MK ;
ZAMVIL, SS ;
MCDEVITT, HO ;
STEINMAN, L .
CELL, 1988, 54 (02) :263-273
[2]   INSULIN-DEPENDENT DIABETES-MELLITUS AS A BETA-CELL TARGETED DISEASE OF IMMUNOREGULATION [J].
BACH, JF .
JOURNAL OF AUTOIMMUNITY, 1995, 8 (04) :439-463
[3]   PROINSULIN AUTOANTIBODIES ARE MORE CLOSELY ASSOCIATED WITH TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS THAN INSULIN AUTOANTIBODIES [J].
BOHMER, K ;
KEILACKER, H ;
KUGLIN, B ;
HUBINGER, A ;
BERTRAMS, J ;
GRIES, FA ;
KOLB, H .
DIABETOLOGIA, 1991, 34 (11) :830-834
[4]   PREVENTION OF DIABETES IN THE NOD MOUSE - IMPLICATIONS FOR THERAPEUTIC INTERVENTION IN HUMAN-DISEASE [J].
BOWMAN, MA ;
LEITER, EH ;
ATKINSON, MA .
IMMUNOLOGY TODAY, 1994, 15 (03) :115-120
[5]   ISLET-SPECIFIC T-CELL CLONES FROM NONOBESE DIABETIC MICE EXPRESS HETEROGENEOUS T-CELL RECEPTORS [J].
CANDEIAS, S ;
KATZ, J ;
BENOIST, C ;
MATHIS, D ;
HASKINS, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6167-6170
[6]   T-CELL RECEPTOR BETA-CHAIN USAGE IN MYELIN BASIC PROTEIN-SPECIFIC RAT LYMPHOCYTES-T [J].
CHLUBA, J ;
STEEG, C ;
BECKER, A ;
WEKERLE, H ;
EPPLEN, JT .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (02) :279-284
[7]   SHARED T-CELL RECEPTOR GENE USAGE IN EXPERIMENTAL ALLERGIC NEURITIS AND ENCEPHALOMYELITIS [J].
CLARK, L ;
HEBERKATZ, E ;
ROSTAMI, A .
ANNALS OF NEUROLOGY, 1992, 31 (06) :587-592
[8]  
CRAWFORD M, 1997, IN PRESS TRANSPLANT
[9]  
DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430
[10]   Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23) [J].
Daniel, D ;
Wegmann, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :956-960